Related by context. Frequent words. (Click for all words.) 82 FDA Accepts 80 Initiates Phase II 77 Drug Candidate 77 Presents Positive 77 Completes Enrollment 76 Phase III Clinical Trial 75 Patient Enrollment 74 Initiate Phase 74 Pivotal Phase III 74 FDA Clears 73 Clinical Trial Results 73 Initiates Phase 73 Phase III Trial 73 Preclinical Data 73 Generic Version 72 Recombinant Human 72 Pivotal Study 71 Single Dose 71 Pivotal Trial 70 Announces FDA Clearance 70 Develop Novel 70 Inc Therapeutic Competitors 70 Metastatic Melanoma 70 Pivotal Phase 70 Receives FDA Clearance 69 Significantly Improves 69 submitted Biologics License 69 Announces Initiation 69 Achieves Milestone 68 Announces Publication 68 Panzem R 68 Files Shelf Registration Statement 68 Small Molecule 68 Release Tablets 68 Well Tolerated 68 FDA Approves 68 refractory chronic lymphocytic 67 Delayed Release 67 Kuvan R 67 Transcept Pharmaceuticals 67 Receives Positive 67 Significantly Reduces 67 MKC# 67 Complete Response 67 RNAi Therapeutics 67 FDA Clearance 67 II Clinical Trial 66 Extended Release 66 Application BLA 66 Ambrisentan 66 Monoclonal Antibody 66 Marketing Authorization Application 66 Pulmonary Arterial Hypertension 66 Positive Opinion 66 BPAX 66 Clinical Trial Application 66 Receives Regulatory 66 Shows Promise 66 Receives Patent 66 Study Demonstrates 66 Anti Inflammatory 66 Low Dose 65 Patent Issued 65 application sNDA 65 Patent Covering 65 DRRX 65 Announces Stockholder Approval 65 IND Investigational New 65 Reduces Risk 65 CRTX 65 BioDelivery Sciences 65 FDA Complete Response 65 GVAX R 65 Cholesterol Drug 65 Irinotecan 65 Inhibits 65 Tesetaxel 65 Announces Presentation 65 liposomal formulation 65 Q1 Loss Narrows 65 Regains Compliance 65 Commercialize 65 ONTY 65 Significantly Increases 65 Secures Financing 65 Epratuzumab 65 Q2 Loss Narrows 65 DVAX 65 Announces Positive 64 Patients Treated 64 Provides Guidance 64 Act PDUFA date 64 Smallpox Vaccine 64 Biologics License Application BLA 64 Inc. Nasdaq IMGN 64 Copegus R 64 Announces Dismissal 64 KRN# 64 Atopic Dermatitis 64 Extended Release Tablets 64 Idera Pharmaceuticals